Posted by Kristin Bloink | 06/01/2020
Elanco’s research and development efforts focus on innovating products but also on changing the approach to innovation in animal health across the world, writes Kristin Bloink, Vice President, Global Research and External Innovation. Here, she comments on developments in the animal health care sector in Asia.
In companion animal, future opportunities for animal health across Asia are emerging from the need to improve facilities and support for stable populations of ageing pets (especially cats) in mature markets like Japan, as well as enabling basic care for rapidly increasing pet populations across South East Asia and China. As with many other parts of the world, pets are increasingly viewed as ’part of the family‘ and pet owners are motivated to treat their animals for disease, and prevent parasites.
However, the channel environment for companion animal healthcare products is at various development stages across Asia and the online and over-the-counter segments have different growth drivers compared to the US and Europe. Companies, like Elanco, are factoring that into our approaches to product innovation, market dynamics and customer support.
In the livestock animal sector, all eyes are on the response and recovery from the spread of African Swine Fever in China and to other Asian countries, and how it will change livestock systems across the region. Increased farm sizes, tighter regulatory requirements and more sophisticated animal husbandry practices will require rapid investments in biosecurity tools and bioprotection products, greater focus on disease preventatives, and farm management support.
All of these market dynamics help to shape Elanco’s consideration of new innovation opportunities in Asia and across the rest of the world.
Importantly, innovation isn’t just about products. It’s about disrupting the traditional innovation model by leveraging internal capabilities while partnering with start-ups, venture funds, and other partners in the venture ecosystem.
Elanco has a global footprint, we understand the value of geographic expansion particularly in Asia and South America, and we strive to be a partner of choice for companies and research organisations developing new products and technologies that can benefit from our scale, reach and capabilities.
I would like to highlight the contribution Japanese scientists have made to Elanco’s innovation legacy over many years, and our ongoing efforts to work with local partners to commercialize their technologies in the animal health environment. Examples included collaborations on key molecules in our parasiticide portfolio, used in products that now enjoy global reach and have been helping to care for pets and livestock around the world for decades.
Undoubtedly, animal health innovation is plentiful and emerging from more sources than at any other time in recent history. Yet, it is the Asia region that’s the one to watch, as it will experience some of the greatest growth and opportunity.
For more information about Elanco innovation, visit www.elanco.com/research-development.